Treatment Education for Perinatal Women and Their Community Support

Treatment Education for Pre- and Postpartum Women and Their Community Support

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06733649

Enrollment

Registered

2024-12-13

Start date

2026-12-06

Completion date

2027-12-05

Last updated

2026-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid Dependency

Keywords

opioid dependence, perinatal women, social support

Brief summary

The study evaluates the feasibility and acceptability of a 50 minute treatment education session for perinatal women with opioid use disorder and a community support person. The education session provides correct information about opioid agonist medications and neonatal abstinence syndrome.

Detailed description

Perinatal women with opioid disorder often face criticism by social network members for receiving opioid agonist treatment. Feeling stigmatized by others may impact willingness to start and remain in agonist treatment. The present study evaluates the feasibility and acceptability of a 50 minute treatment education session for perinatal women who are treated using an agonist medication (methadone or buprenorphine) and community support chosen by the patient. Study participants will be recruited from perinatal women who receive substance abuse treatment at the Center for Addiction and Pregnancy or Addiction Treatment Services at Johns Hopkins Bayview campus. These women will work with a counselor to select a community support person to bring to the program for the education session. The session will provide correct information on opioid agonist medications and neonatal abstinence syndrome. This session will follow a structured outline.

Interventions

OTHERsubstance abuse treatment education

Perinatal women and the women's community support will receive a 50 minute education session that provides correct information on opioid agonist medications and neonatal abstinence syndrome.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Intervention model description

Perinatal women and the woman's community support will receive one treatment education session.

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* perinatal women treated with agonist medication * interest in study participation * interest in community support: * interest in study participation

Exclusion criteria

* perinatal women not treated with agonist medication * not interested in study participation * not interested in community support: * not interested in study participation

Design outcomes

Primary

Measure	Time frame	Description
Percentage of women interested in study participation	Immediately before session 1	Feasibility -- percentage of women interested in study participation
Percentage of interested women who bring in community support to the education group	Immediately before session 1	Acceptability -- proportion of interested women who bring in community support to the education group

Secondary

Measure	Time frame	Description
Knowledge as assessed by survey	Baseline, Immediately after session 1	Women and the womens' community support will complete a 10 question true / false test before and after the education session

Contacts

CONTACTMichael Kidorf, Ph.D.

mkidorf@jhmi.edu410 550 0006

CONTACTDenis Antoine, MD

antoine@jhmi.edu410 550 7843

PRINCIPAL_INVESTIGATORMichael Kidorf, Ph.D.

Johns Hopkins University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 23, 2026